Related references
Note: Only part of the references are listed.Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing
Raghavan Chinnadurai et al.
STEM CELLS (2016)
Bone Marrow Mesenchymal Stromal Cells Isolated From Multiple Sclerosis Patients Have Distinct Gene Expression Profile and Decreased Suppressive Function Compared With Healthy Counterparts
Gislane L. V. de Oliveira et al.
CELL TRANSPLANTATION (2015)
Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis
Sara Llufriu et al.
PLOS ONE (2014)
Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
Guido Moll et al.
STEM CELLS (2014)
Actin Cytoskeletal Disruption following Cryopreservation Alters the Biodistribution of Human Mesenchymal Stromal Cells In Vivo
Raghavan Chinnadurai et al.
STEM CELL REPORTS (2014)
Mesenchymal stem cell transplantation in multiple sclerosis
Jeffrey A. Cohen
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
A Randomized Trial of Mesenchymal Stem Cells in Multiple System Atrophy
Phil Hyu Lee et al.
ANNALS OF NEUROLOGY (2012)
Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
Moira Francois et al.
CYTOTHERAPY (2012)
Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis
Violaine K. Harris et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Peter Connick et al.
LANCET NEUROLOGY (2012)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu et al.
PLOS ONE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Dimitrios Karussis et al.
ARCHIVES OF NEUROLOGY (2010)
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study
Bassem Yamout et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group
Mark S. Freedman et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis
Elizabeth Mallam et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Differences in mesenchymal stem cell cytokine profiles between MS patients and healthy donors: Implication for assessment of disease activity and treatment
Benedetta Mazzanti et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
Ida Rasmusson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
MR1 criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study
Josephine K. Swanton et al.
LANCET NEUROLOGY (2007)
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
N Eliopoulos et al.
BLOOD (2005)
Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis
HA Papadaki et al.
BONE MARROW TRANSPLANTATION (2005)
Bone marrow transdifferentiation in brain after transplantation: a retrospective study
CR Cogle et al.
LANCET (2004)
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
ON Koç et al.
BONE MARROW TRANSPLANTATION (2002)
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
B Bielekova et al.
NATURE MEDICINE (2000)
Share Paper
